Corcept Therapeutics Incorporated (CORT) Ownership

$77.65

$0.84 (1.09%)
Last update: 04:00 PM EST
Day's range
$76.4
Day's range
$78.26

Corcept Therapeutics Incorporated Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/02/2025 14.69 M $1.68 B   -6.31% 14.11%
VANGUARD GROUP INC 05/09/2025 9.98 M $1.14 B   -1.32% 9.59%
INGALLS & SNYDER LLC 05/12/2025 7.74 M $884.36 M   -4.41% 7.44%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 6.14 M $701.66 M   -0.90% 5.90%
PARALLEL ADVISORS, LLC 04/08/2025 3.97 M $219.65 M   3.73% 3.82%
STATE STREET CORP 05/15/2025 3.40 M $388.57 M   -4.13% 3.27%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 2.26 M $258.99 M   9.28% 2.17%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 2.14 M $243.71 M   2.79% 2.05%
MORGAN STANLEY 05/15/2025 1.54 M $175.73 M   21.97% 1.48%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2025 1.49 M $170.44 M   -9.28% 1.43%
FMR LLC 05/12/2025 1.48 M $168.91 M   10.60% 1.42%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2025 1.35 M $154.16 M   -1.98% 1.30%
INVESCO LTD. 05/12/2025 1.25 M $142.34 M   76.49% 1.20%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.03 M $117.84 M   -1.89% 0.99%
NORTHERN TRUST CORP 05/13/2025 1.02 M $116.73 M   0.64% 0.98%
FIRST TRUST ADVISORS LP 05/14/2025 924.32 K $105.58 M   -13.14% 0.89%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/12/2025 751.22 K $85.80 M   -5.72% 0.72%
D. E. SHAW & CO., INC. 05/15/2025 700.26 K $79.98 M   -21.01% 0.67%
MAN GROUP PLC 05/15/2025 629.18 K $71.86 M   118.55% 0.60%
CERITY PARTNERS LLC 04/30/2025 614.79 K $70.22 M   1.13% 0.59%
CAPTION MANAGEMENT, LLC 05/15/2025 613.30 K $70.05 M   484.10% 0.59%
JUPITER ASSET MANAGEMENT LTD 05/09/2025 603.90 K $68.98 M   8,176.04% 0.58%
BOSTON TRUST WALDEN CORP 04/21/2025 584.80 K $66.80 M   -34.95% 0.56%
BANK OF NEW YORK MELLON CORP 04/29/2025 583.09 K $66.60 M   -1.13% 0.56%
PRINCIPAL FINANCIAL GROUP INC 04/28/2025 530.46 K $60.59 M   2.54% 0.51%
GOLDMAN SACHS GROUP INC 05/16/2025 505.35 K $57.72 M   -19.31% 0.49%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 405.20 K $46.28 M   302.38% 0.39%
LMR PARTNERS LLP 05/15/2025 403.90 K $46.13 M   100.00% 0.39%
BRAUN STACEY ASSOCIATES INC 04/29/2025 366.62 K $41.88 M   23.69% 0.35%
FRANKLIN RESOURCES INC 05/13/2025 333.09 K $38.05 M   21.58% 0.32%
05/12/2025 311.50 K $35.58 M   100.00% 0.30%
ABRDN PLC 05/13/2025 308.55 K $35.24 M   -29.21% 0.30%
RUSSELL INVESTMENTS GROUP, LTD. 05/13/2025 307.29 K $35.10 M   51.74% 0.30%
TWO SIGMA ADVISERS, LP 05/15/2025 306.80 K $35.04 M   -19.64% 0.29%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 302.92 K $34.60 M   -26.52% 0.29%
FAS WEALTH PARTNERS, INC. 05/05/2025 300.26 K $34.30 M   -2.89% 0.29%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/12/2025 295.74 K $33.78 M   27.29% 0.28%
JPMORGAN CHASE & CO 05/12/2025 290.78 K $33.21 M   11.88% 0.28%
IKARIAN CAPITAL, LLC 05/15/2025 287.90 K $32.88 M   100.00% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 287.80 K $32.87 M   0.91% 0.28%
MILLENNIUM MANAGEMENT LLC 05/15/2025 281.96 K $32.21 M   -44.53% 0.27%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2025 271.15 K $30.97 M   -43.67% 0.26%
LEGAL & GENERAL GROUP PLC 05/15/2025 270.14 K $30.86 M   -2.88% 0.26%
BURNEY CO/ 05/06/2025 266.40 K $30.43 M   -43.78% 0.26%
AMERIPRISE FINANCIAL INC 05/14/2025 264.58 K $34.82 M   -16.62% 0.25%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 259.65 K $29.66 M   100.00% 0.25%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 253.03 K $28.90 M   -8.52% 0.24%
JANUS HENDERSON GROUP PLC 05/15/2025 246.84 K $13.48 M   -18.13% 0.24%
SQUAREPOINT OPS LLC 05/15/2025 236.83 K $27.05 M   100.00% 0.23%
COOKSON PEIRCE & CO INC 05/13/2025 235.82 K $26.94 M   544.26% 0.23%

Corcept Therapeutics Incorporated institutional Ownership - FAQ's

During the previous two years, 522 institutional investors and hedge funds held shares of Corcept Therapeutics Incorporated. The most heavily invested institutionals were:

BlackRock, Inc.: 14.69 M

VANGUARD GROUP INC: 9.98 M

INGALLS & SNYDER LLC: 7.74 M

RENAISSANCE TECHNOLOGIES LLC: 6.14 M

Parallel Advisors, LLC: 3.97 M

STATE STREET CORP: 3.4 M

78.99% of Corcept Therapeutics Incorporated stock is owned by institutional investors.

Institutional investors have bought a total of 109.98 M shares in the last 24 months. This purchase volume represents approximately $8.55 B in transactions.